Poly Medicure (POLYMED.NS) Stock Price

Poly Medicure Price

NSE·CLOSED
1,641.20
​
Market closed

Revenue has compounded at 17.7% per year over the past 19 years to 18.75 B INR. Earnings per share have grown at 21.3% per year over the last 19 years. Poly Medicure's net margin stands at 17.2%, up from 15.9% several years earlier. Poly Medicure currently offers a dividend yield of about 0.21%. The payout ratio is around 13% of earnings. The dividend has grown at 17.3% per year over the past 14 years. Analysts set a median price target of 2,228.70 INR, implying 35.8% above the current price. Of 11 analysts, 8 rate the stock a buy — an overall Buy consensus.

Poly Medicure stock price

Access this data via the Eulerpool API

Poly Medicure business model & stock analysis

Poly Medicure Ltd. engages in the provision and sales of medical devices. The company is headquartered in Faridabad, Haryana and currently employs 2,339 full-time employees. The company went IPO on 2011-12-05. The firm is primarily in the business of manufacture and sale of medical devices. The firm offers a diverse portfolio of medical devices in the product verticals of infusion therapy, oncology, anesthesia and respiratory care, covid care, urology, gastroenterology, blood management and blood collection, surgery and wound drainage, dialysis, central venous access catheters, veterinary medical devices, and others. The company supplies its products to approximately 120 countries, in Europe, Africa, Americas, Australia, and Asia. Its products include suction control valve, safety arterial cannula, VTM Kit, VLTM kit, blood collection needle with flashback, and pre-filled syringes. The firm operate nine manufacturing facilities across India, China, Egypt, and Italy. In India, it operates six manufacturing facilities, four of which are situated at Faridabad (Haryana), and one each in Jaipur (Rajasthan) and Haridwar (Uttarakhand).

Frequently asked questions about Poly Medicure

Analysts currently set an average price target of 2,195.72 INR for the Poly Medicure stock (median: 2,228.70 INR), implying +33.8 % versus the latest price. The consensus is based on 11 analyst ratings.

11 analysts currently rate the Poly Medicure stock: 8 recommend buying, 3 holding and 0 selling.

Converted at the current exchange rate, the Poly Medicure share trades at 15.35 EUR (1,641.20 INR).

The Poly Medicure share (POLYMED.NS) is listed on 2 stock exchanges, including: NSE (Indien) (POLYMED.NS).

The revenue of Poly Medicure is 18.75 B INR. This figure is based on current financial data and reflects the company's business performance.

The profit of Poly Medicure is 3.22 B INR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Poly Medicure is currently 51.68. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Poly Medicure stock.

The price-to-sales ratio (P/S) of Poly Medicure is currently 8.88. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Poly Medicure stock.

The Eulerpool Quality Score for Poly Medicure is 6/10.

The ISIN of Poly Medicure is INE205C01021. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Poly Medicure is POLYMED.NS. The ticker symbol is used to trade Poly Medicure shares on the stock exchange.

Fair ValueTerminal
1,706.85 INR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
8.02 M INR
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
INR
Initial public offering
Dec 5, 2011
ISIN
INE205C01021
Cusip
Y7062A142
Market capitalization
166.35 B INRLarge Cap
52-Week Range
PEG
3.26
P/E ratio
P/Ee 2027
41.80
P/Ee 2028
34.30
P/Ee 2029
26.88
P/S
P/Se
7.17
EV/EBIT
51.72
P/B Ratio
5.36
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
9.31 %
Dividend
Dividend yield
0.21 %
Est. Dividend Yield
0.21 %
Payout Ratio
12.75 %
Dividend growth Ø5Y
6.96 %
Dividend payments per year
1
Dividend paid since
14 years
Dividend not reduced since
8 years
Dividend increased since
1 year
Dividend withholding tax
20.00 %
Last updated Oct 13, 2026, 8:04 AM

Poly Medicure Peer Group

Poly Medicure Ticker

BSE · POLYMED.BONSE INDIA · POLYMED.NS

Poly Medicure FIGI

PLM:IN · BBG000GV1XZ1PLM:IB · BBG000GV1YF1PLM:IS · BBG000GV1Z40PLM:IG · BBG003NW1H17PLMINR:EO · BBG01HQ0SPP9PLMINR:X2 · BBG01HQ0SPQ8PLMINR:XH · BBG01HQ0SPS6PLMINR:XF · BBG01HQ0SPV2PLMINR:XE · BBG01HQ0SPX0PLMINR:XJ · BBG01HQ0SPY9PLMINR:XL · BBG01HQ0SPZ8PLMINR:XG · BBG01HQ0SQ04